CSIR-IGIB has partnered with which organisation for the commercialisation of gene therapy?
- AAIIMS
- BSerum Institute of India
- CICMR
- DDRDO
Solution & Step-by-step Explanation
The Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB) has partnered with the Serum Institute of India (SIIPL) to license and commercialise its indigenous high-fidelity CRISPR-Cas9 platform (enFnCas9), targeting gene therapies for diseases like sickle cell anemia.